This distinction is crucial and defines its unique therapeutic potential
When AMPK is active, cells burn excess stored fat, inflammation is held in check, and metabolic pathways function at peak efficiency
Athletes & gym-goers aiming to burn fat & enhance endurance
Key outcomes: Mean weight loss: 14.9% (vs 2.4% placebo) 86.4% of participants achieved 5% loss (vs 31.5% placebo) 50.5% achieved 15% loss (vs 4.9% placebo) SELECT (Lincoff et al., NEJM 2023) added the cardiovascular signature: in 17,604 non-diabetic adults with prior CV history, semaglutide 2.4 mg reduced MACE (CV death, MI, stroke) by 20% over 3 years
Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis
Make the choice for a luminous complexion todayyour skin will thank you